Stoke Therapeutics, Inc. (STOK)
Healthcare • Biotechnology
StockNasdaqGSUnited StatesUS86150R1077
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Stoke Therapeutics, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 14:35. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 15 Mar 2027 17:00 | -1.19 | — | — | Upcoming |
| 29 Oct 2026 16:00 | -0.91 | -1.08 | -18.1% | Miss |
| 03 Aug 2026 16:00 | -0.78 | -0.93 | -19.1% | Miss |
| 07 May 2026 16:00 | -0.82 | -0.79 | +3.1% | Beat |
| 16 Mar 2026 16:00 | -0.74 | -0.97 | -31.8% | Miss |
| 04 Nov 2025 16:00 | -0.57 | -0.65 | -13.2% | Miss |
| 12 Aug 2025 16:00 | -0.54 | -0.40 | +25.5% | Beat |
| 13 May 2025 07:00 | -0.09 | 1.90 | +2,198.8% | Beat |
| 18 Mar 2025 07:00 | -0.53 | -0.18 | +66.1% | Beat |
| 05 Nov 2024 07:00 | -0.54 | -0.47 | +13.2% | Beat |
| 07 Aug 2024 07:00 | -0.56 | -0.46 | +18.6% | Beat |
| 06 May 2024 07:00 | -0.61 | -0.57 | +6.8% | Beat |
| 25 Mar 2024 16:00 | -0.63 | -0.60 | +4.3% | Beat |
| 07 Nov 2023 07:00 | -0.64 | -0.55 | +14.7% | Beat |
| 07 Aug 2023 07:00 | -0.66 | -0.69 | -4.4% | Miss |
| 04 May 2023 07:00 | -0.71 | -0.53 | +25.9% | Beat |
| 06 Mar 2023 07:00 | -0.71 | -0.65 | +9.1% | Beat |
| 14 Nov 2022 07:00 | -0.68 | -0.66 | +2.4% | Beat |
| 08 Aug 2022 07:00 | -0.69 | -0.63 | +8.6% | Beat |
| 10 May 2022 07:00 | 0.13 | -0.66 | -590.5% | Miss |
| 10 Mar 2022 07:00 | -0.61 | -0.66 | -8.5% | Miss |
| 08 Nov 2021 07:00 | -0.55 | -0.61 | -11.6% | Miss |
| 10 Aug 2021 07:00 | -0.46 | -0.60 | -30.0% | Miss |
| 10 May 2021 07:00 | -0.44 | -0.46 | -5.1% | Miss |
| 09 Mar 2021 07:00 | -0.42 | -0.42 | +0.9% | In line |
| 12 Nov 2020 07:00 | -0.43 | -0.41 | +4.6% | Beat |
| 10 Aug 2020 07:00 | -0.36 | -0.39 | -8.3% | Miss |
| 15 May 2020 07:00 | -0.37 | -0.34 | +8.9% | Beat |
| 23 Mar 2020 08:00 | -0.30 | -0.09 | +69.6% | Beat |
| 12 Nov 2019 08:00 | -0.28 | -0.26 | +5.8% | Beat |
| 14 Aug 2019 08:00 | -1.63 | -1.54 | +5.4% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 184.4M | +404.5% | -6.9M | -3.7% | -0.12 | +92.7% | 44.9M |
| 2024 | 36.6M | +316.3% | -89M | -243.4% | -1.65 | +30.7% | -87.1M |
| 2023 | 8.8M | -29.2% | -104.7M | -1,192.5% | -2.38 | +8.5% | -82.7M |
| 2022 | 12.4M | — | -101.1M | -814.7% | -2.60 | — | -35.8M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 13 Nov 2026 | 26.12 | 26.82 | 26.00 | 26.39 | +0.71% | 19,235 | |
| 12 Nov 2026 | 27.51 | 27.70 | 26.14 | 26.20 | -5.62% | 501,200 | |
| 11 Nov 2026 | 27.25 | 27.99 | 26.52 | 27.76 | +2.02% | 836,800 | |
| 10 Nov 2026 | 27.55 | 28.43 | 26.80 | 27.21 | -1.80% | 838,300 | |
| 09 Nov 2026 | 27.27 | 27.89 | 26.41 | 27.71 | +4.41% | 1,060,000 | |
| 06 Nov 2026 | 26.49 | 26.72 | 25.96 | 26.54 | +1.80% | 1,162,600 | |
| 05 Nov 2026 | 27.50 | 27.50 | 25.94 | 26.07 | -5.03% | 1,215,400 | |
| 04 Nov 2026 | 27.75 | 27.75 | 26.60 | 27.45 | +1.70% | 1,210,000 | |
| 03 Nov 2026 | 26.84 | 27.52 | 26.63 | 26.99 | +1.93% | 1,727,600 | |
| 02 Nov 2026 | 26.32 | 27.03 | 25.80 | 26.48 | +0.72% | 1,404,400 | |
| 1,246 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Stoke Therapeutics (STOK) Faces A Valuation Test Following Weaker Nine Month Results (opens in a new tab) Simply Wall St. · 07 Nov 2026 04:26
- Stoke Therapeutics (STOK) Stock Price Faces Q3 Results Cash Burn Question (opens in a new tab) Simply Wall St. · 31 Oct 2026 22:11
- Stoke (STOK) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 30 Oct 2026 14:29
- Stoke Therapeutics, Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 30 Oct 2026 12:30
- Stoke Therapeutics Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 30 Oct 2026 02:14
- Stoke Therapeutics, Inc. (STOK) Reports Q3 Loss, Tops Revenue Estimates (opens in a new tab) Zacks · 29 Oct 2026 22:05
- FDA Alignment on Zorevunersen Endpoints Could Be A Game Changer For Stoke Therapeutics (STOK) (opens in a new tab) Simply Wall St. · 10 Oct 2026 00:09
- Stoke Therapeutics shares rise as JPMorgan starts coverage with Overweight rating (opens in a new tab) InvestorsHub · 21 Aug 2026 10:53
- Stoke Therapeutics’ Dravet Trial Tops Enrollment Target With Zero Dropouts (opens in a new tab) MarketBeat · 18 Aug 2026 01:01
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 26.20 USD
- Market cap
- 1.7B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow STOK and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.